Welcome to LookChem.com Sign In|Join Free
  • or
3-Quinolinecarbonitrile, 1,2,5,6,7,8-hexahydro-4-(2-thienyl)-2-thioxo- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

120517-52-4

Post Buying Request

120517-52-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

120517-52-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 120517-52-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,5,1 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 120517-52:
(8*1)+(7*2)+(6*0)+(5*5)+(4*1)+(3*7)+(2*5)+(1*2)=84
84 % 10 = 4
So 120517-52-4 is a valid CAS Registry Number.

120517-52-4Downstream Products

120517-52-4Relevant academic research and scientific papers

ACETYL-COA CARBOXYLASE MODULATORS

-

Paragraph 00251-00255, (2015/01/09)

Provided herein are compounds that exhibit activity as acetyl-CoA carboxylase modulators (e.g., inhibitors) and are useful, for example, in methods for the control of fungal pathogens in plants.

Synthesis and structures of (S)- and (R)-2-[3-cyano-4-(2-thienyl)-5,6,7, 8-tetrahydroquinolin-2-ylsulfanyl]-3-methyl-N-phenylbutyramide

Yao, Zhiyi,Du, Xiaojie,Liu, Hong,Jiang, Hualiang,Chen, Kaixian

, p. 3 - 5 (2007/10/03)

(S)- and (R)-2-[3-cyano-4-(2-thienyl)-5,6,7,8-tetrahydroquinolin-2- ylsulfanyl]-N-phenyl-3-methylbutyramide (1a and 1b) were prepared from 2-thiophenaldehyde and D- and L-valines, respectively, and their crystal structures were elucidated by X-ray crystallography.

SUBSTITUTED PYRIDO[3', 2': 4, 5]THIENO[3,2-D]PYRIMIDINES AND PYRIDO[3', 2': 4, 5]FURO[3, 2, D]PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNFΓ(A)

-

Page/Page column 94-95, (2010/02/15)

The invention relates to compounds of general formula (I); 1a, 1 b, 1 c and 1 d. The invention also relates to a method for the production thereof, pharmaceutical preparations containing said compounds and/or physiologically compatible salts thereof which can be produced therefrom and/or solvates thereof, and to the pharmaceutical use of said compounds, salts or solvates thereof as inhibitors of phosphodiesterase 4. The compounds comprise active ingredients for the treatment of diseases which can have a positive influence by inhibiting the activity of phosphodiesterase 4 and/or TNFα-release, for example, in lymphocytes, eosinophile and basophile granulocytes, macrophages and mastocytes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 120517-52-4